The National Institutes of Health has launched an online data portal to collect clinical information on neurological symptoms, complications and outcomes related to COVID-19.
News
Latest
Drug maker Eli Lilly and Company said its neutralizing antibodies cocktail of bamlanivimab and etesevimab combine to significantly reduce hospitalizations and deaths attributed to COVID-19.
Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.
The public health emergency will likely remain in place through 2021, and the administration will give states 60 days’ notice before it decides to terminate the emergency or let it expire.
The Food and Drug Administration reissued emergency use authorizations for 10 systems authorized to decontaminate certain N95 respirators.
Pfizer Inc. has completed enrolling children aged 12 to 15 in a COVID-19 vaccine study, the drug maker confirmed.
AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.”
An estimated one in five people in the United States had a sexually transmitted infection at some point in 2018, with almost half of new infections in those under age 25, the Centers for Disease Control and Prevention reported.
This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.
In this Members in Action podcast, Julia Resnick, AHA senior program manager, speaks with leaders from CHI Health’s Creighton University Medical Center about how a culture enabled by interdisciplinary care teams is improving value for their patients.
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and supporting the physical and mental health of all staff.
The Commonwealth Fund issued a report outlining recommendations for federal investments in health.
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
“We have much to do, much to repair, much to restore, much to heal, much to build … and much to gain.”
U.S. deaths involving methamphetamines increased more than five-fold from 2011 to 2018, to 10.1 per 100,000 men and 4.5 per 100,000 women, according to a study reported yesterday in JAMA Psychiatry.
This year’s AHA Rural Health Care Leadership Conference offers a unique opportunity for leaders to connect before, during and after the conference in affinity groups.
The Department of Health and Human Services’ Office for Civil Rights formally published in the Federal Register a proposed rule released Dec. 10 that would modify HIPAA privacy standards for individually identifiable health information.
Hospitals in 2019 provided $41.6 billion in uncompensated care, meaning care for which no payment was received from the patient or insurer, according to the latest data from the AHA's Annual Survey of Hospitals.
Over 100 rural hospitals have closed since 2013, resulting in patients traveling a median 20 miles farther for health care services, according to a report released by the Government Accountability Office.